Kyntra Bio, Inc.

KYNB Nasdaq SEC CIK 921299
Follow Kyntra Bio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.8M +63.8% vs same quarter last year
Net income $157K −99.9% vs same quarter last year
EPS, diluted $0.04 −99.9% vs same quarter last year
Operating cash flow −$12.2M −563% vs same quarter last year
Revenue by quarter
$3.1M
$2.7M
$1.3M
$1.1M
$1.3M
$3.7M
$1.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$6.4M$183.5M
FY24$29.6M−$47.6M
FY23$46.8M−$284.2M
FY22$140.7M−$293.7M
FY21$235.3M−$290M
FY20$176.3M−$189.3M
FY19$256.6M−$77M
FY18$213M−$86.4M
FY17$131M−$120.9M
FY16$183.2M−$58.1M
FY15$180.8M−$85.8M
FY14$137.6M−$59.5M
FY13$102.2M−$14.9M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000%0%1000%2000%3000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2591.4%−712.7%2848.6%
FY2447.5%−507.8%−160.6%
FY2391.5%−689.5%−607.3%
FY2285.6%−213.9%−208.7%
FY2194.5%−122.6%−123.3%
FY2095%−108.8%−107.4%
FY1999.6%−34.8%−30%
FY18-−40.7%−40.6%
FY17-−89.5%−92.3%
FY16-−27.3%−31.7%
FY15-−42.9%−47.4%
FY14-−36.4%−43.2%
FY13-−7.8%−14.6%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$300M−$200M−$100M$0$100MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$4.8M
FY24−$138.3M
FY23−$317.5M
FY22−$149.7M
FY21−$87.4M
FY20$77.6M
FY19−$84.5M
FY18−$84.2M
FY17−$75M
FY16$5.9M
FY15−$20.5M
FY14$14.3M
FY13$19.1M
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Kyntra Bio
  • Healthcare median
−1000%0%1000%2000%3000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearKyntra BioHealthcare median
FY252848.6%−30.6%
FY24−160.6%−47%
FY23−607.3%−58%
FY22−208.7%−80.4%
FY21−123.3%−71.9%
FY20−107.4%−62.2%
FY19−30%−46.3%
FY18−40.6%−49.6%
FY17−92.3%−45.9%
FY16−31.7%−36%
FY15−47.4%−38.4%
FY14−43.2%−35.5%
FY13−14.6%−37.1%
FY12-−29.1%